Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,344 | 315 | 99.7% |
| Education | $13.89 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,507 | 105 | $0 (2024) |
| Novo Nordisk Inc | $802.83 | 53 | $0 (2023) |
| Gilead Sciences, Inc. | $459.95 | 19 | $0 (2023) |
| Biohaven Pharmaceutical Holding Company Ltd. | $320.40 | 27 | $0 (2022) |
| Abbott Laboratories | $305.18 | 10 | $0 (2023) |
| Biohaven Pharmaceuticals, Inc. | $268.46 | 15 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $235.59 | 15 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $175.23 | 13 | $0 (2023) |
| GlaxoSmithKline, LLC. | $163.84 | 12 | $0 (2023) |
| ViiV Healthcare Company | $147.50 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $50.63 | 3 | Lilly USA, LLC ($19.92) |
| 2023 | $1,074 | 66 | AbbVie Inc. ($423.61) |
| 2022 | $1,920 | 128 | ABBVIE INC. ($598.68) |
| 2021 | $1,494 | 83 | AbbVie Inc. ($434.65) |
| 2020 | $425.04 | 25 | Novo Nordisk Inc ($104.17) |
| 2019 | $255.12 | 7 | Gilead Sciences, Inc. ($185.26) |
| 2018 | $110.08 | 2 | PFIZER INC. ($96.19) |
| 2017 | $28.84 | 2 | Merck Sharp & Dohme Corporation ($16.07) |
All Payment Transactions
316 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.18 | General |
| Category: Cardiovascular | ||||||
| 01/22/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: NEUROSCIENCE | ||||||
| 01/16/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Diabetes | ||||||
| 12/26/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: Diabetes Care | ||||||
| 12/14/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Diabetes | ||||||
| 12/05/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/27/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $16.75 | General |
| 11/15/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/08/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Diabetes | ||||||
| 11/02/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $32.34 | General |
| Category: Oncology | ||||||
| 10/25/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.11 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.41 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2023 | AbbVie Inc. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: NEUROSCIENCE | ||||||
| 09/28/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $7.61 | General |
| Category: Diabetes | ||||||
| 09/20/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: NEUROSCIENCE | ||||||
| 09/07/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.48 | General |
| Category: Diabetes | ||||||
| 08/30/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/29/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Gastroenterology | ||||||
| 08/24/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.63 | General |
| Category: NEUROSCIENCE | ||||||
| 08/23/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 604 | 740 | $134,447 | $34,137 |
| 2022 | 12 | 660 | 779 | $139,499 | $39,088 |
| 2021 | 12 | 677 | 824 | $131,156 | $46,715 |
| 2020 | 12 | 667 | 833 | $116,831 | $36,376 |
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 148 | 229 | $42,823 | $9,957 | 23.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 127 | 127 | $40,132 | $5,693 | 14.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 63 | 69 | $13,593 | $4,943 | 36.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 15 | 15 | $11,910 | $4,224 | 35.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 76 | 102 | $12,852 | $3,853 | 30.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 65 | 73 | $2,628 | $2,143 | 81.6% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 12 | 12 | $5,256 | $1,716 | 32.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 18 | 18 | $774.00 | $528.48 | 68.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 34 | 44 | $1,188 | $418.88 | 35.3% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 11 | 14 | $1,106 | $317.20 | 28.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 17 | 19 | $817.00 | $177.07 | 21.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 18 | 18 | $1,368 | $165.82 | 12.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 31 | 31 | $24,614 | $8,654 | 35.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 125 | 185 | $34,548 | $8,509 | 24.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 114 | 159 | $20,034 | $6,225 | 31.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 117 | 117 | $36,972 | $5,755 | 15.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 62 | 62 | $12,214 | $4,243 | 34.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 65 | 65 | $2,340 | $1,818 | 77.7% |
| 0054A | Adm sarscv2 30mcg trs-sucr b | Office | 2022 | 25 | 25 | $2,000 | $929.42 | 46.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 33 | 33 | $1,419 | $926.29 | 65.3% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 23 | 23 | $1,840 | $848.93 | 46.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 11 | 13 | $1,352 | $532.18 | 39.4% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 32 | 42 | $1,134 | $403.21 | 35.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 22 | 24 | $1,032 | $244.96 | 23.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 128 | 128 | $40,448 | $16,710 | 41.3% |
About Dr. Jaynine Vado, DO
Dr. Jaynine Vado, DO is a Hospice and Palliative Medicine healthcare provider based in Columbus, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2011. The National Provider Identifier (NPI) number assigned to this provider is 1073808408.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jaynine Vado, DO has received a total of $5,357 in payments from pharmaceutical and medical device companies, with $50.63 received in 2024. These payments were reported across 316 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($5,344).
As a Medicare-enrolled provider, Vado has provided services to 2,608 Medicare beneficiaries, totaling 3,176 services with total Medicare billing of $156,316. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Practice Information
- Specialty Hospice and Palliative Medicine
- Other Specialties Internal Medicine
- Location Columbus, OH
- Active Since 06/14/2011
- Last Updated 04/24/2024
- Taxonomy Code 207RH0002X
- Entity Type Individual
- NPI Number 1073808408
Products in Payments
- NURTEC ODT (Drug) $588.86
- UBRELVY (Drug) $542.65
- Ozempic (Drug) $496.13
- VRAYLAR (Drug) $392.35
- QULIPTA (Drug) $339.00
- FreeStyle Libre 2 (Device) $222.54
- FARXIGA (Drug) $220.64
- Kerendia (Drug) $175.23
- Rybelsus (Drug) $164.10
- APRETUDE (Biological) $147.50
- CREON (Drug) $109.65
- Descovy (Drug) $103.85
- LINZESS (Drug) $97.56
- CHANTIX (Drug) $96.19
- SHINGRIX (Biological) $88.40
- Biktarvy (Drug) $81.41
- RYBELSUS (Drug) $78.30
- ZENPEP (Drug) $77.02
- WELLBUTRIN (Drug) $62.62
- FREESTYLE LIBRE 2 (Device) $62.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospice and Palliative Medicine Doctors in Columbus
Timothy Moore, Md, MD
Hospice and Palliative Medicine — Payments: $264,128
Dr. Joseph Tu, M.d, M.D
Hospice and Palliative Medicine — Payments: $5,575
Dr. Roger Garcia, D.o, D.O
Hospice and Palliative Medicine — Payments: $4,099
David Laubli, Do, DO
Hospice and Palliative Medicine — Payments: $569.91
Dr. Tommy Petros, M.d, M.D
Hospice and Palliative Medicine — Payments: $431.38
Frank Savage, Do, DO
Hospice and Palliative Medicine — Payments: $185.83